Facebook
X
LinkedIn
Forward
0844_CPMC_Non-Invasive Neuromodulation for Neurological and Psychiatric Disorders_Live
Description:
This virtual grand rounds addresses a critical knowledge gap among clinicians regarding non-invasive neuromodulation therapies for treatment-resistant psychiatric and neurological conditions. The session will equip participants to identify current FDA-approved neuromodulation options for psychiatric disorders and emerging therapies for acute seizures and drug-resistant epilepsy. Attendees will explore the underlying mechanisms of action for these innovative treatment modalities and learn to recognize key factors that influence both efficacy and tolerability outcomes, enabling more informed clinical decision-making for patients with medically refractory mood disorders and seizures.
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
Moens, M., Pilitsis, J. G., Poree, L., Azurin, Y., Billot, M., Roulaud, M., ... & Goudman, L. (2024). Socioeconomic Determinants of Initiating Neuromodulation for Chronic Pain: A Systematic Review. Neuromodulation: Technology at the Neural Interface, 27(8), 1266-1284. LINK TO ARTICLE
Lavazza, A. (2017). Can neuromodulation also enhance social inequality? Some possible indirect interventions of the state. Frontiers in Human Neuroscience, 11, 113. LINK TO ARTICLE
Target Audience
Physicians (MD or DO)
Learning Objectives
By the end of this learning activity, learners will be able to:
1.) Identify FDA-approved non-invasive neuromodulation therapies for psychiatric disorders
2.) Identify emerging non-invasive neuromodulation modalities for treatment of acute seizures and drug-resistant focal epilepsy
3.) Review the mechanism of action of these modalities
4.) Recognize factors that explain efficacy and tolerability variability
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
Kenneth Laxer, planner for this presentation, receives speaker fees from SK Life Sciences. This ineligible relationship was deemed not relevant to this Grand Rounds topic and therefore did not require mitigation.
David King-Stephens, speaker for this presentation, receives compensation for consulting & speaking work performed with Neurelis, UCB, SK Life Sciences & Elsai. These are deemed relevant financial relationships on the topic of neuromodulation. Sutter Health has mitigated these relationship via peer review, performed by Eric Collins, MD.
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Fozia Ferozali, EdD
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: Non-Physician Participation Credits (AKA - AMA PRA Category 1 Credits HOURS™) Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Physician Credit
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Non-Physician Participation Credit
Sutter Health designates this Live activity for a maximum of 1.00 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.